Nuria Quintana

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

María‐Victoria Mateos, Miguel‐Teodoro Hernández, Pilar Giraldo et al. · New England Journal of Medicine · 2013 · 569 citations · Full text

Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial

María‐Victoria Mateos, Miguel‐Teodoro Hernández, Pilar Giraldo et al. · The Lancet Oncology · 2016 · 186 citations

Hematological Malignancy, Oncology, Immunology +6

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination

Sonia López-Giral, Nuria Quintana, María Cabrerizo et al. · Journal of Leukocyte Biology · 2004 · 168 citations

Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia

Manuel Alfonso-Pérez, Sonia López-Giral, Nuria Quintana et al. · Journal of Leukocyte Biology · 2006 · 59 citations

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

María‐Victoria Mateos, Lucía López‐Corral, Miguel‐Teodoro Hernández et al. · Blood · 2009 · 36 citations